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Abstract   Kenya faces major socio-economic and health challenges since the independent 1963. Tuberculosis, 
HIV/AIDS and malaria are the leading causes of morbidity and mortality in Kenya. The Government of Kenya has 
been trying to build a health system which can effectively provide quality health services to the population of the 
country. In Kenya, health services are provided through a network of over 5,000 health facilities countrywide. The 
country spends 5.1% of its GDP on health sector. As a result both mortality and morbidity rates are decreasing in 
Kenya. Infant and under-5 mortality rates are high in the country compare to the some other developing countries. 
Despite many attempts are taken by the Government yet the health sector of Kenya is far to reach the Millennium 
Development Goals. The paper discusses aspects of health of Kenya to make a healthy nation in the world.  
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1. Introduction 
 
     Republic of Kenya is the 4th largest economy in 
Sub-Saharan Africa (SSA) and Nairobi is its capital 
city. Mombasa is the main sea port of the country. 
Kenya is named after a mountain (5,199 m above sea 
level) of the same name of the country. Its area is 
580,400 km2, which is 49th largest country in the 
world and water area is 11,227 km2 (2.3% of the total 
area), 80% of total land area is arid or semi-arid and 
forest area is 6% of the total land. It is the 6th most 
populated country in SSA and 31st largest populated 
country in the world with estimated 45 million 
inhabitants in 2014 (of which about 75–80% lives in 
rural areas), with a majority under-15. The density of 
population in Kenya is 69 persons/km2, which is the 
140th densely populated country in the world [28]. 
     Kenya lies between latitudes 5o N and 5o S and 
between longitudes 34o E and 42o E. It is almost 
bisected by the equator. The country is divided into 
seven ecological zones: Tropical Alpine, Upper 
Highland, Lower Highland, Upper Midland, Lower 
Midland, Lowland and Coastal Lowland [11]. 
     More than 60% people of Kenya live below the 
poverty line (less than $1.25 a day or unable to afford 
to buy food providing a daily intake of 2,100 
kilocalories). Like other SSA countries, Kenya faces 
major socio-economic and health challenges. Kenya 
signed in the global Millennium Development Goals 
(MDGs) in 2000 to guide prioritization of countries 
as they move towards improvement of their 
development. The country also has specifically 
defined its long term Vision, the Vision 2030 that 
elaborates what the country intends to focus on as it 
moves towards a medium income country by 2030 
[9].  
    The Government of Kenya (GoK) has been trying 
to build a health system which can effectively 
provide quality health services to the population of 
the country. Life expectancy (at birth) of the total 
population in 2013 was about 63.29 years (male 
61.84 years and female 64.77 years) compared to a 
global average of 68 years. Loss of healthy life-years 
(about 48 years) is about 82% due to infectious 
disease. The persistence of malaria, tuberculosis and 
the progression of the HIV/AIDS epidemic have 
contributed to the fall in life expectancy and the rise 
in mortality rates, particularly for infants and under-5 
[8]. 
     A new Kenya Health Policy (2012–2030) was 
adopted by the Government in 2012. It is associated 
to the 2010 constitution and the country’s long-term 
development agenda. The health policy embraces this 
long-term vision and has made use of the primary 
health centre (PHC) approach to focus on the 
attainment of the right to health for all citizens as 
provided for in the constitution. A Government-wide 
medium-term development plan (MTP) is at 
advanced stage of development. Alongside the MTP 
is a National Health Strategic Plan (NHSSP III) also 
at advanced stage of development [66].  
     In Kenya infant mortality rate is about 58.1 per 
1,000 live births. The overall under-5 child mortality 
rate is about 121 per 1,000 live births, which is 
double of the global average and maternal mortality 
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rate is about 414 per 1,000 [9]. Kenya has high 
morbidity and mortality rates affecting the population 
of all ages, especially children under-5. A significant 
proportion of this morbidity and mortality is due to 
infectious conditions, but many other non-infectious 
factors are chronic diseases and economic 
deprivation resulting in poverty, malnutrition and 
inadequate health care. About 15 women die every 
day due to pregnancy related complications in Kenya 
and 20% of all deaths among mothers in the country 
are AIDS related [20].   
     It has been estimated that about 200 people die of 
the disease in Kenya every day and all these deaths 
are preventable. Tuberculosis, Human 
immunodeficiency virus (HIV)/Acquired immune 
deficiency syndrome (AIDS) and malaria are the 
leading causes of morbidity and mortality in Kenya 
[66].   
     Malaria is a leading cause of childhood morbidity 
and mortality worldwide. It is estimated that about 
732,000 deaths of world among children under-5 is 
due to malaria, among them Africa accounts 16% [3]. 
Kenya adopted a new National Malaria Strategy 
(NMS) in 2001, which emphasized the distribution of 
insecticide treated bed nets (ITNs) for short in line 
and recommended selective indoor residual spraying 
(IRS) for epidemic control and prompt treatment, and 
prophylactic treatment. Kenya is working towards 
achieving the Abuja targets of 80% ITN coverage. 
Malaria has been eradicated from most of the 
countries of the world, but it remains threats to many 
people of Africa. About 80% of the world’s malaria 
cases and 90% of malaria-related deaths occur in 
SSA. In 2010, there were 174 million estimated cases 
of malaria on the African and about 600,000 deaths 
are recorded. In Kenya about 70% of the population 
is at risk from malaria, which kills an estimated 
34,000 children under-5 each year [1]. 
 
Kenya is one of the 22 high TB burden countries of 
the world. According to the WHO Global 
Tuberculosis Report 2010 Kenya is 13th ranked. 
Kenya reported more than 106,083 TB cases in 2010 
with more than 4,000 deaths. About 297 Health 
professionals are deployed by the GoK to be engaged 
in TB control programme including 46 at national, 36 
at provincial and 215 at district level technically 
reporting to Division of Leprosy, TB, and other lung 
disease (DLTLD) [65]. 
 
     In Kenya about 7% of adults, and 6% of rural 
residents, are infected with HIV. Rates of infection 
amongst women are almost twice as high as those of 
men (8.7% to 4.6%), which reflect the particular 
vulnerability of young women to HIV infection 
compared with young men. In Kenya 1 child in 9 is 
orphaned. About 9% of children under-15 have lost 
their fathers, 4% have lost their mothers, and 2% 
have lost both of their parents. Only 58% of children 
live with both parents [5]. In 2003, there were 
650,000 AIDS orphans in Kenya. In 2008, the 
Government began providing free antiretroviral drugs 
(ARVs) to HIV-positive people who need them, and 
medical care is now free for children under-5 [44].   
    Children are also vulnerable to diarrhea and 
pneumonia. There was unreliable evidence of a rise 
in typhoid in several areas, due to increasingly 
difficult access to clean potable water, poor sanitation 
and overcrowded housing conditions. It is hard to 
find clean water, because good wells are miles from 
the home. Many parents have no concept of what a 
balanced diet is [18]. 
     In Kenya, 12% of the population is obese and 
most of them are found in urban areas. In Kenya 
obesity is considered a sign of wealth. In real life 
obesity is a major disease which creates Type 2 
diabetes and cardiac attack. Obesity has increased 
along with Type 2 diabetes in the urban areas of 
Kenya. If a person is slim others will consider him as 
a HIV/AIDS infected person. For this reason AIDS 
infected people took more food to show others that 
they are not infected by this fatal disease. 
Additionally in Kenya fast food availability has 
increased in the cities. Cities are developed without 
the scope of the facilities of exercise [27].  
     Childhood vaccination coverage in Kenya  has 
declined, with a fall of the proportion of children 
aged 12–23 months fully vaccinated from 79% in 
1993 to 52% in 2003 [13]. Infant and under-5 
mortality rates are increasing, from 73% and 105% 
respectively in 1989–1993 to 77% and 115% in 2003. 
The under-5 mortality rate is higher in rural areas. 
The rates vary greatly by province, and according to 
mothers’ level of education. Except for neonatal 
mortality, all childhood mortality indicators were 
highest in Nyanza Province and lowest in the Central 
Province [6]. The level of maternal mortality is very 
high in Kenya [54]. 
    The patients expect high quality of services in 
hospitals and other health care centers. Quality in 
healthcare may comprise of newer technology, newer 
and effective medication, and higher staff to patient 
ratios, affordability, efficiency and effectiveness of 
service delivery [47]. 
    Total expenditure on healthcare increased from 
$219 million in 2005 to $277.5 million in 2007, and 
between 2004 and 2008 the number of health 
institutions increased by 19.8% in Kenya [44].  
 
    We have analyzed the secondary data to prepare 
the article. The data are collected from the annual 
reports of Ministry of Health of Kenya, Country 
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Profiles of Kenya, Global and Kenyan WHO reports 
on health and diseases, various research articles, and 
websites on health. 
         
2. Background of Health Policy of 
Kenya  
 
     Health is defined being not only the absence of 
disease but also general mental, physical, and social 
well-being. Good health is renowned as a vital pillar 
in ensuring the prosperity of individual, household, 
community of a country. People seek good health to 
maximize their health stock, to ensure they are able 
to carry out the activities that will improve their 
overall social welfare. All persons in a society are 
responsible for creating the conditions that ensure the 
health stock available is maximized [17]. 
     Kenya’s health policy has been based on the 
country’s landmark post-colonial nation-building and 
socio-economic development [59]. Since 
independence the GoK has given high priority to the 
improvement of the health sector of the country [20]. 
In the 1970s health indicators in Kenya deteriorated 
from the mid-1980s with the growing population and 
worsening socio-economic and political environment, 
and a severe social development crisis occurred in the 
1990s [30]. Since 1994, the health sector 
development agenda has been guided by the Kenya 
Health Policy Framework Paper (KHPFP) up to 
2010. The economy grew to about 6% in 2006 and 
healthcare reforms were intensified in an attempt to 
reduce the household burden of accessing primary 
health services.   
     In Kenya death rate has declined from 20 per 
1,000 person in 1963 to 13 in 1987, and 12 in 1991. 
Life expectancy increased from 40 to 58 years in 
1960 and 1994; infant mortality declined from 126 
per 1000 in 1962 to 60 per 1000 in 1994, and the 
immunization coverage rose to 70% in 1994 from 
less than 40% at independence in 1963 [34]. 
     In 1994, the Government of Kenya (GoK) 
approved the Kenya Health Policy Framework 
(KHPF) as a blueprint for developing and managing 
health services. The development of the 1st National 
Health Sector Strategic Plan (NHSSP-I, 1999–2004) 
was a follow-up to the Ministry of Health’s (MoH) 
efforts to translate the policy objectives into an 
implementable programme. The strategic objectives 
of NHSSP-I are; (i) strengthening governance, (ii) 
improving resource allocation, (iii) decentralization 
of health services and management, (iv) shift of 
resources from curative to preventive and PHC 
services, (v) provision of autonomy to provincial and 
national hospitals and (vi) enhancing collaboration 
with stakeholders under a Sector Wide Approach 
(SWAp) modality [20]. 
     The 2nd  National Health Sector Strategic Plan’s 
(NHSSP II, 2005–2010) strategic objectives, to 
contribute to the reduction of health inequalities and 
to reverse the downward trend in health related 
impact and outcome indicators that had been noted 
during the implementation of the NHSSP-I. Its 
strategic objectives are; (i) increase equitable access 
to health services, (ii) improve quality and the 
responsiveness of services in the sector, (iii) improve 
the efficiency and effectiveness of service delivery, 
(iv) foster partnerships in improving health and 
delivering services, and (v) improve financing of the 
health sector [17].   
 
 
3. Health Sector of Kenya 
 
     The health sector of Kenya comprises of three 
owner systems, with the Government running 41%, 
the Non-governmental organizations (NGOs) 15%, 
and private businesses 43%, which provide mainly 
curative health services and very few preventive 
services. The Government owns most of the 
hospitals, health centers, and dispensaries. On the 
other hand clinics and nursing homes are entirely in 
the hands of the private sector. The best-off Central 
Province has about twice the number of facilities per 
population as the worst-off provinces, such as, 
Nyanza and Western Valley. Central, Coast, and 
Eastern provinces have better ratios than the national 
average. In 2002 total number of health personnel 
was 59,000 of them 5,000 was doctors [59]. 
     In Kenya, health services are provided through a 
network of over 5,000 health facilities countrywide. 
The public health sector consists of the following 
levels of health facilities [45]:  
• national referral hospitals,  
• provincial general hospitals,  
• district hospitals, and 
• health centers, and dispensaries. 
    National referral hospitals are at the apex of the 
health care system, which provide sophisticated 
diagnostic, therapeutic, and rehabilitative services. 
The two national referral hospitals in Kenya are 
Kenyatta National Hospital in Nairobi and Moi 
Referral and Teaching Hospital in Eldoret. The 
equivalent private referral hospitals are Nairobi 
Hospital and Aga Khan Hospital in Nairobi. They are 
centers of excellence and provide complex health 
care requiring more complex technology and highly 
skilled personnel [60]. 
       Provincial hospitals form a secondary level of 
health care for their location. They provide services 
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to a geographically well-defined area. They provide 
specialized care, involving skills and competence not 
available at district hospitals, which makes them the 
next level of referral after district hospitals. Their 
personnel include medical professionals, such as 
general surgeons, general medical physicians, 
paediatricians, general and specialized nurses, 
midwives, and public health staff. These hospitals 
provide medicine, obstetrics and gynaecology, 
accident and emergency services, ear, nose and throat 
(ENT) dental services, general surgery and 
anaesthesia, paediatrics, psychiatry, ophthalmology, 
dermatology, intensive care unit (ICU) and high 
dependency unit (HDU) services [17]. 
      District hospitals provide very specialized care at 
the district level, maintain quality standards, and 
coordinate and control all district health activities. 
They are the first referral hospital and form an 
integral part of the district health system. These 
hospitals concentrate on the delivery of health care 
services and generate their own expenditure plans 
and budget requirements based on guidelines from 
headquarters through the provinces. At the district 
level, curative services are provided by district 
hospitals and mission hospitals. Public health 
services are managed by the District Health 
Management Team (DHMT) and Public Health Unit 
of the district hospitals. The DHMT and District 
Health Management Board (DHMB) provide 
management and supervision support to rural health 
facilities. District hospitals offer quality clinical care 
by a more skilled and competent staff than those of 
the health centers and dispensaries. They provide 
accident and emergency services, obstetrics and 
gynaecology, child health, medicine, surgery, 
including anaesthesia [9].  
      Health centers are staffed by midwives or nurses, 
clinical officers, and occasionally by doctors. They 
provide preventive and curative services, mostly 
adapted to local needs. They also provide a wider 
range of services, such as basic curative and 
preventive services for adults and children, as well as 
reproductive health services. They also provide minor 
surgical services such as incision and drainage. They 
augment their service coverage with outreach 
services, and refer severe and complicated conditions 
to the appropriate level, such as the district hospital 
[45]. 
     The dispensaries are at the lowest level of the 
public health system and are the first point of contact 
with patients. But in some areas, health centers or 
even hospitals are effectively the first points of 
contact. They are staffed by enrolled nurses, public 
health technicians and medical assistants. The 
enrolled nurses provide antenatal care and treatment 
for simple medical problems during pregnancy such 
as anaemia, and occasionally conduct normal 
deliveries. Dispensaries provide wider coverage for 
preventive health measures, which is a primary goal 
of the health policy. At the sub-district level, both 
preventive and curative services are provided by the 
health centers as well as dispensaries and outreach 
services to the communities within the catchment 
areas [44].  
     Highly skilled physicians, nurses, administrators, 
and ancillary staff are critical to producing high-
quality treatment and growth of hospital in Kenya 
[2]. 
 
4. Malaria 
 
     Malaria is a disease caused by parasites of the 
genus Plasmodium. According to Dr. Teresa 
Omwoyo, the National Health and Nutrition 
Coordinator for World Vision Kenya, malaria is the 
number one killer of children and women in Kenya 
[46]. Malaria is a serious and potentially fatal 
disease. Kenya is in the 5th rank in a list of African 
region which account for 90% of malaria cases. 
Nigeria, Democratic Republic of Congo (DRC), 
Ethiopia and Tanzania make up the top four of the 19 
country list [61]. About 30 million out of a 
population of 45 million (about 3 out of 4) Kenyans 
are at risk of malaria. Kenya has 63 malaria-endemic 
districts (out of total 72 districts) where 73% of 
country’s population at risk of malaria. Among them 
16 are in the highland malaria epidemic prone 
districts and the 8 arid and semi-arid districts have an 
unstable malaria epidemiological pattern [64].  
 
4.1 Statistics of Malaria in Kenya 
 
     In Kenya, 1.5 million women become pregnant 
each year, and the majority live in malaria endemic 
areas. Pregnant women, children under-5 and the 
elderly are particularly vulnerable to serious infection 
of malaria due to their low immunity. Pregnant 
women who are suffering from malaria not only 
become anaemic but also are at risk of delivering 
babies with low birth weight.  
     Fetal complications of pregnant women may 
include low birth weight, abortion, stillbirth, 
prematurity, intrauterine growth retardation or 
congenital malaria infection. Pregnant women are 10 
times more likely to contract malaria than non-gravid 
women. Pregnant women who contract malaria have 
a greater tendency to develop severe malaria [64].  
      Effectiveness of malaria in Kenya varies from 
region to region and the risk increase by altitude, 
rainfall patterns and temperature. Lake Victoria 
(Nyanza and the Western regions) endemic region 
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(altitudes ranging from 0 to 1,300 m) is high malaria 
transmission area for all year long and prevalence 
rate is 20–40%. Coast area is another endemic region 
of malaria transmission all year long which 
prevalence less than 5%. The vector life cycle is 
usually short and survival rates are high because of 
the suitable climatic conditions in these regions. 
Highland endemic region is the second malaria 
transmission area and prevalence rate is 0–20%. Arid 
and semi-arid areas are of northern and south-eastern 
parts of the country which experience short periods 
of malaria transmission only during the rainfall 
seasons where prevalence is less than 5%. 
Temperatures are usually high and water pools 
created during the rainy season provide breeding sites 
for the malaria vectors. Epidemic outbreaks with high 
morbidity rates happen due to the low immune status 
of the population when these areas are flooded. 
Malaria transmission in the Western Highlands of 
Kenya is seasonal and epidemics are experienced 
when long rains favor with minimum temperatures 
around 180C and sustain vector breeding, results in 
increased intensity of malaria transmission and the 
epidemic becomes ten times greater than those 
experienced in regions where malaria occurs 
regularly. Central Highlands including Nairobi are of 
low risk area where little or no malaria transmission 
happens and prevalence rate is 0.1% [44]. 
     In 2013, Kenya lost more than 46,000 people from 
malaria. According to World Health Organization 
(WHO) each year about 34,000 children under-5 die 
from malaria in Kenya (7,843 in Rift Valley, 5,878 in 
Eastern, 5,400 in Coast, 3,909 in Nyanza, 3,103 in 
Western, 389 in Central, 419 in Nairobi, and 141 in 
North-eastern). All four species of human 
Plasmodium: Plasmodium falciparum, Plasmodium 
malariae, Plasmodium ovale and Plasmodium vivax 
occur in Kenya and Plasmodium falciparum which 
causes the severest form of the disease accounts for 
98.2% of all malaria infections, while P. malariae, P. 
ovale is 1.8% often occurring as mixed infections 
[41, 44]. 
     About 30–50% of all outpatient morbidity and 
20% of inpatient admissions in hospitals are due to 
malaria and about 170 million working days are lost 
annually due to malaria illness and each Kenyan 
family spends KSh 1,400 or more annually to treat 
malaria. It is estimated that malaria accounts for 
about 6% of all deaths and 20–25% of deaths in 
children under-5 have been certified to malaria in 
Kenya. Only 1 out of 10 children under-5 in the 
Lake-endemic region sleeps in a home that has been 
sprayed. Only 1 out of 50 dispensaries use the 
malaria rapid diagnostic tests and 2 out of 3 
dispensaries do not diagnose malaria by blood tests 
[24]. 
      Malaria is the reason of complications in 
pregnancy and can lead to early miscarriage. In 
Kenya out of 3 pregnant women living in the malaria 
endemic area around Lake Victoria does not use 
preventive malaria drugs. 2 out of 5 pregnant women 
in the Highlands endemic region do not sleep under 
ITN. 1 out of 7 women in areas where malaria is 
rampant does not seek antenatal care [44].  
 
4.2 Control of Malaria 
 
      To combat malaria, in 2001, the Ministry of 
Health (MoH) through the National Malaria Control 
Programme (NMCP) developed the National Malaria 
Strategy (NMS) covering the period 2001–10, which 
emphasized the increased use of ITNs [26]. By the 
late 1990s, there was considerable evidence that the 
use of ITNs reduced childhood mortality in SSA [22]. 
Before 2001 mosquito net use was limited in Kenya. 
In 2002, Population Services International (PSI) 
Kenya received support from the UK Department for 
International Development to market partially 
subsidized ITNs across Kenya. The ITNs were priced 
at $4.7 in urban areas and at $1.3 in rural areas. In 
2004, Kenya received a Global Fund grant to 
distribute 5 million long lasting insecticide nets 
(LLINs) free of charge to children under-5 [36].  
      Kenya has achieved a steady increase in 
household ownership of ITNs from 2004 to 2008. 
There have been tremendous gains in the ITN 
coverage rising from as low as 4.6% in 2003 to about 
50.2% in 2008 for both pregnant women and children 
under-5, after a free mass ITN distribution but in the 
malarious regions ITNs rose to 60%. In the highly 
malarious Nyanza and Western regions, household 
ownership of ITNs rose from 5.3% and 2.4% in 2003 
to 76.5% and 71% respectively by 2008–09. In 2002–
08 periods, an estimated 16 million ITNs and LLINs 
were distributed in Kenya through various channels 
[21].  
     In collaboration with partners, the Government 
has developed the 10-year Kenyan National Malaria 
Strategy (KNMS) 2009–2017 which was launched in 
November 4, 2009. The goal of the National Malaria 
Strategy (NMS) is to reduce morbidity and mortality 
associated with malaria by 30% by 2009 and to 
maintain it to 2017. More than 50% of pregnant 
women used ITN by the year 2008 for most 
provinces except Central and Rift Valley which had 
less 30% of pregnant women using ITN. There has 
been an overall increase in the coverage rate of ITN 
use by children under-5 (50%) from 2003 and 2008 
[64]. 
     National malaria strategy recommended for 1 ITN 
for every 2 people but in malaria endemic areas there 
is 1 ITN to 5 Kenyans. Two out of 5 children under-5 
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in the malaria endemic Nyanza and Coast regions do 
not sleep under ITN. The current ITN ownership of 
0.8 per household in Kenya is far from universal 
access defined as 2 nets per household. The main 
goal of the National Malaria Strategy (NMS) was to 
reduce the level of malaria infection and consequent 
death by 30% by the year 2006 and to sustain that 
improved level of control to 2010.  
      To achieve the goal, the current MoH policy on 
malaria recommends several strategies as follows 
[17]: 
• All pregnant women living in areas prone to 
malaria should have access to at least 2 free 
sulphadoxine-pyrimethamine (SP) doses, or 
2 Intermittent Prophylactic Treatment (IPT) 
doses. 
• The policy also provides for personal 
protection to people at risk of malaria 
especially young children and pregnant 
women through increased access to ITN and 
IRS services. 
• All fevers in children under-5 be 
presumptively treated as malaria with 
artemesinin combination treatment (ACT) 
and improved laboratory diagnosis, which is 
provided free of charge at Government and 
mission facilities. 
• Improvement of epidemic preparedness and 
response. 
• Application of cross-cutting strategies, such 
as, Information, Education and 
Communication (IEC) for Behavior Change 
Communication (BCC), Health Systems 
Strengthening (HSS) strategic actions, as 
well as effective monitoring and evaluation. 
      Pregnant women living in malaria endemic areas 
should get at least 2 doses of IPT, along with the 
prerequisite of effective case management for 
anaemia and malaria during pregnancy to reduce 
morbidity and mortality of both mother and child 
[39]. The proportion of women who received at least 
2 doses of IPT rose from 4% in 2002 to 24.5% in 
2006 in sentinel districts and to 13% in all malaria 
endemic districts in 2007. In 2009, the Government 
vision of a Malaria-Free Kenya emerged as a result of 
the development of a multi-sector malaria control 
strategy 2009–2017 with clear and focused strategic 
approaches and objectives [17].  
      The National Malaria strategy recommended 
selective use of indoor residual house-spraying (IRS) 
in the early detection phase of epidemics. IRS is 
carried out in highland 16 malaria epidemic-prone 
districts. The strategy is to spray over 80% of the 
households in malaria epidemic-prone district to 
minimize transmission. The proportion of targeted 
IRS rose from 27.1% in 2005 to 63% in 2008. The 
intensity of IRS campaigns fluctuated due to 
inconsistent flow of financing. For example, in 2008, 
63% of the targeted houses were sprayed which 
covered protection to about 3.1 million people, but in 
2009, only 33% of the target was reached due to 
delays in donor fund disbursement. IRS is also 
affected due to poor quality control of pumps and 
insecticides [41]. 
      Over the last 10 years, Kenya has made progress 
in malaria control. However, the country is still far 
from defeating the disease. The main reasons for this 
are poor knowledge of the disease and the lack of 
diagnostic equipment in health facilities, not sleeping 
under ITNs, lack of taking anti-malarial drugs during 
pregnancy. To roll back malaria, the Government 
must invest more in new initiatives and tools for 
fighting it even as it makes use of emerging 
epidemiological knowledge of the disease [64]. 
 
4.3 Malaria Prevention 
 
     Actually no malaria prevention treatment is 100% 
effective. Malaria risk can be reduced by avoiding 
mosquito bites by applying various techniques, such 
as, wearing long-sleeved shirts, sleeping under nets 
or in screened rooms, staying indoors or screened 
areas at dusk and using insect repellents and 
mosquito coils [61]. 
 
4.4 Treatment Facilities of Malaria in 
Kenya 
 
    If a pregnant woman becomes infected, the 
antimalarial and antiprotozoal drugs used to treat 
malaria and are safe for use during pregnancy for the 
mother and the fetus. Children need a shorter course 
for rapidly progressing to severe malaria. Children 
with severe malaria are more likely to present with 
hypoglycemia, seizures, severe anemia and sudden 
death, but they are much less likely to develop renal 
failure, pulmonary edema or jaundice. Cerebral 
malaria results in neurologic sequelae in 9–26% of 
children. Children usually recover even from severe 
malaria much faster than the adults. If proper dosage 
is given, most antimalarial drugs are very effective 
and safe in children [64].  
     In Kenya 1 in 4 children with fever received some 
formulation of anti-malarial, only about 1 in 10 of 
these receives the treatment within 24 hours of fever. 
About 1 in 20 of children receives an appropriate first 
line anti-malarial drug [44]. 
     P. falciparum is resistant to chloroquine treatment. 
Primaquine is required in the treatment of P. ovale 
and P. vivax infection in order to eliminate the 
hypnozoites. Non-immune pregnant women in 
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endemic areas use the proper pharmacologic and non-
pharmacologic prophylaxis. For an infected pregnant 
woman the anti-malarial and anti-protozoal drugs use 
are safe for both the mother and the fetus. In the 
sexual stage of the protozoan (the gametocyte) does 
not respond to most standard medications (e.g., 
chloroquine, quinine), but gametocytes eventually die 
and do not cause a threat to the individual’s health 
[61].  
     Standard antimalarials, such as, chloroquine and 
antifolates (sulfadoxine pyrimethamine), are 
ineffective in many areas of Africa, because of 
increasing prevalence of drug resistance and a high 
likelihood of resistance development to new agents. 
Combination therapy is now becoming the standard 
of care for treatment of P. falciparum infection [57]. 
     The treatment policy for malaria has changed 
since 1998 due to failing therapeutic efficacy from 
chloroquine to sulphadoxine-pyrimethamine (SP) and 
subsequently to the currently recommended 
artemisinin-based combination therapies (ACTs) in 
2004. At present ACTs that are co-formulated are the 
best treatments for uncomplicated malaria and the 
efficacy of the treatments of malaria in Kenya [44]. It 
is strongly recommended that ACTs should include at 
least 3 days of treatment with an artemisinin 
derivative [64]. 
     The commonly used confirmatory tests to detect 
the presences of malaria parasites in Kenya are 
microscopy or rapid diagnostic tests (RDTs). 
Microscopy is the standard method for 
parasitological diagnosis of malaria and is performed 
by examining a stained thick or thin blood smear for 
the presence of malaria parasites. RDTs are 
immunochromatographic simple tests based on 
detection of specific parasite antigens [44]. 
     The first line treatment for uncomplicated malaria 
in Kenya is artemether-lumefantrine (AL) tablet 
containing 20 mg of artemether and 120 mg of 
lumefantrine. This is advised as a 6-dose schedule 
given over three days. The recommended second line 
treatment for uncomplicated malaria in Kenya is 
dihydroartemisinin-piperaquine (DHA-PPQ). This is 
currently available as a fixed-dose combination with 
adult tablets containing 40 mg of dihydroartemisinin 
and 320 mg of piperaquine and paediatric tablets 
containing 20 mg dihydroartemisinin and 160 mg of 
piperaquine. These are advised once daily for three 
days. The recommended treatments for severe 
malaria are parenteral quinine or parenteral 
artemisinins (artesunate or artemether). The preferred 
route of administration is the intravenous route [44]. 
 
4.5 Knowledge Gap 
 
     One out of 11 mothers in Kenya does not believe 
that malaria medicine can cure a child’s fever. 
Children of the richest Kenyans under-5 are 5 times 
more likely to have their blood tests for malaria when 
they have a fever compared to children of the 
poorest. Out of 3 mothers in the semi-arid seasonal 
mothers believe that a child’s fever should first be 
treated with herbs. Too many mothers do not believe 
that malaria medicine can cure a child’s fever. More 
than half of the mothers in the Coast-endemic area 
have not heard, watched or read any information 
about the most common anti-malaria medicine [61].  
      Kinung’hi et al. [19] in a survey of very small 
amount of villagers of Muleba district of North-
western Tanzania found that some people believe 
malaria can cause due to bedbugs (0.6%), ticks 
(1.6%), contaminated water (15%), basking in sun-
shine (2.6%), working in the rains (1%) and 
witchcraft (0.4%) and similar results are found in 
other countries of SSA including Kenya. But most of 
them are confirm that malaria causes through the 
mosquito bites.  
 
4.6 Progress in Reduction of Malaria in 
Kenya 
 
The Global Fund, the GoK and the African Medical 
and Research Foundation signed in a grant agreement 
worth $80 million to reduce malaria morbidity and 
mortality in Kenya by two-thirds by 2017 [64].  
 
In recent years a remarkable progress has been made 
in malaria control in Kenya. This is due to 
widespread distribution of ITNs and LLINs and 
household spraying have helped large parts of the 
country become free from malaria [9]. 
 
Amount of pregnant women in malaria prevalence 
areas who receive two or more doses of IPTp during 
their pregnancy will have increased to 50%. The 
household use of at least one ITN has increased to 
70%. The pregnant women sleeping under an ITN the 
previous night have increased to 60%. About 95% of 
houses in malaria prevalence areas targeted for IRS 
have been sprayed. Antimalarial drug use also has 
increased in Kenya [44]. 
 
5. Tuberculosis (TB) in Kenya 
 
      Tuberculosis is caused by Mycobacterium 
tuberculosis also called Acid-Alcohol Fast Bacilli 
(AAFB) because of its staining properties. M. 
tuberculosis was discovered by Dr. Robert Koch in 
1882. Transmission of this fatal disease is by droplet 
nuclei infection through coughing and sneezing. The 
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incidence of TB is increased due to its association 
with HIV/AIDS, poverty, malnutrition and 
overcrowding [29]. 
      Early symptoms of active TB disease are 
coughing up blood more than 2 weeks, unexplained 
weight loss, consistent low-grade fever, chills, 
haemoptysis, excessive night sweats, and loss of 
appetite. TB bacteria can remain in this latent state 
for months, years, and even decades without 
increasing in number and without signs and 
symptoms, or radiographic or making the person sick. 
This is called latent TB infection (LTBI). People who 
have latent TB infection do not get sick, never show 
any symptoms of TB and do not spread the bacteria 
to others. Only about 10% of people infected with M. 
tuberculosis ever develop tuberculosis disease [63]. 
      Kenya is among the top 22 countries that 
collectively contribute to 80% of the world’s TB 
cases and is ranked 13th, and has the 5th highest 
burden in Africa according to the WHO Global 
Tuberculosis Report 2010. Kenya developed a 
national direct observation therapy (DOTS) strategy 
that was finalized in 1991. The DOT treatment 
success rate met WHO’s target of 85% in 2007 [65].  
      In Kenya the number of TB cases was 228 per 
100,000 people in 2007 which is high in the world. 
Kenya reported more than 106,083 TB cases in 2010 
with more than 4,000 deaths. WHO estimated that 
there were around 2,000 cases of multidrug-resistant 
TB (MDR TB) in Kenya in 2007, although only 4.1% 
of these cases were diagnosed and notified. The 
annual budget for adult TB first-time treatment in 
Kenya is Ksh 300 million (150 for the required stock 
and 150 for buffer stock) and an extra Ksh 50 million 
pediatric TB treatment [48]. 
      The TB programme has 12 operational zones (by 
sub dividing four of the largest provinces into 8) and 
215 TB operational districts to facilitate TB control 
activities in Kenya. Most cases of TB in Kenya 
(80%) are pulmonary. In Kenya mainly first-line 
drugs; isoniazid, rifampin, streptomycin, ethambutol 
and pyrazinamide are used to treat the TB. Most 
patients are in drug susceptibility of these medicines. 
The majority of the patients (66.5%) were 
unemployed or self-employed in small businesses, 
with 79.4% earning less than $100 per month. As a 
result they cannot take proper treatment due to 
financial crisis [35]. 
      Both morbidity and mortality due to TB in Kenya 
is a major national health problem. TB affects all age 
groups, but has its greatest toll on those above 15 
years of age. Epidemic HIV, poverty, and rapid 
urbanization led to increase of urban slums, prison 
congestion and limited access to general health care 
services are major causes of burden of TB disease. 
For the growing burden of TB in Kenya, the Ministry 
of Health formed the Division of Leprosy, 
Tuberculosis and Lung (DLTLD) to increase support 
in the followings [17]: 
1. Strengthening of the human resource 
capacity at all levels of the DLTLD for 
effective coordination of TB control 
activities. 
2. Decentralization of TB control services 
down to the community level to increase 
access to services. 
3. Strengthening the collaboration between TB 
and HIV control programmes in order to 
promote delivery of integrated TB/HIV 
services, private–public partnerships to 
increase the number of private providers 
integrated into the TB service provider 
network. 
4. Sustaining public education campaign 
coupled with health care worker training and 
support to promote early care seeking and 
adherence to treatment at community level 
and better TB case management by health 
care provider. 
5. Sustained political commitment to increase 
human and financial resources and 
integrating TB control into the national 
health system. 
6. Uninterrupted supply of quality assured 
drugs with reliable procurement and 
distribution systems. 
      Due to various attempts are taken by the DLTLD, 
the TB case notification rate (CNR) rose from 51 to 
329 per 100,000 populations between 1987 and 2006. 
The treatment success rate has been a steadily 
increasing to a rate of 82 % in the year 2006. Lack of 
emergence of drug resistant TB is a major challenge 
in the fight against TB.  The WHO Global TB report 
for 2009 estimated that Kenya had approximately 
132,000 new TB cases and an estimated 74,000 
people died [62]. There are 2,000 treatment facilities 
and 900 TB diagnosis facilities throughout the 
country but they do not cater to drug-resistant TB. In 
2007, about 2,000 MDR TB cases were in Kenya, 
although only 4.1% of these individuals were 
diagnosed but the Government had no ability to treat 
them. In Kenya, about 20% of the 1.2 million HIV-
positive individuals also have TB [55].  
      Kenya is the first country in SSA to have 
achieved the global targets for both case detection 
and treatment success and the country continues to 
treat more and more TB patients each year. But 
widespread co-infection with HIV (about 48% of new 
TB patients) makes TB diagnoses and treatment 
difficult. In Kenya more than 11% of all TB cases 
notified were children. MDR and childhood TB are 
the two main challenges the country [7]. 
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6. HIV/AIDS in Kenya 
 
     Kenya is 4th largest HIV epidemic country in the 
world. Out of the people 45 million about 1.6 million 
are living with HIV. About 820,000 women aged 15 
and up, and 200,000 children aged 0–14 living with 
HIV. More than 1.1 million children have been 
orphaned by it and 80,000 Kenyan had died from 
AIDS related illnesses in 2012. About 80% of the 
AIDS related deaths occur among adults. In Kenya 
HIV affected all level of people, such as, infants, 
children, young people, women, men and elderly 
persons [56]. The first case of HIV in Kenya was 
detected in 1984, and by the mid 1990s it was one of 
the major causes of mortality in the country. Kenya’s 
HIV prevalence peaked to 11% during the year 2000 
and had been on the decline to 6.1% in 2012 due to 
an increase in awareness and education and the rapid 
scaling up of antiretroviral treatment (ART). Still 
many people are not being reached with HIV 
prevention and treatment services even with the 
steady increase in access of services [51, 52].  
      HIV prevalence among urban adults is about 10% 
and rural adults are about 5.6%. HIV prevalence in 
Nyanza province nearly doubles the national average. 
The estimated number of people living with HIV in 
Wajir is lowest 500, compared to a massive 140,600 
in Homa Bay, 281 times higher [51]. 
      Since 1995 HIV declined by about 40% to reach 
approximately 6.7% in 2003. Since then, the 
prevalence has remained relatively stable. The 
decline of the prevalence from 1995 to 2003 is partly 
attributed to high AIDS related mortality and the 
stabilization of the epidemic in the last 10 years is 
largely due to the rapid scale up of ART and 
reduction in the number of new infections that 
occurred during this period [52]. 
      New infections among adults are more than 80% 
of the total new infections. The new infections among 
adults stabilized at an average of 93,000 annually 
over the last 5 years. Among children, new infections 
declined from about 20,000 (18%) to 11,000 (11%) 
annually over the same period [52].  
      HIV prevalence among men who have sex with 
men (MSM) in Kenya is almost three times (18.2 %) 
that among the general population. In 2011, about 
18.3% of people of inject drugs users (IGUs) in 
Kenya were living with HIV and most of them are in 
Nairobi and Mombasa. Use of condom and safe 
injecting practices are very low among this group and 
are responsible for high rates of HIV transmission 
[52]. Female sex workers and their clients have the 
highest reported HIV prevalence of any group in 
Kenya. About 29.3% of them were living with HIV 
in 2011 but recently they are using condoms [50].   
      Girls in Kenya face discrimination in terms of 
access to education, employment and healthcare. 
They are forced into early marriage and often unable 
to negotiate safe sex. In 2012, about 6.9% of   girls 
and women aged 15–24 were living compared with 
4.2% of men. Young women are almost three times 
(3%) more likely to be living with HIV than men 
(1.1%) of the same age due to lack of knowledge of 
HIV infection among girls [32]. From the above 
statistics HIV prevalence in Kenya are given in figure 
1.  
 
 
 
Figure 1: HIV prevalence rate (%) in Kenya. Source: 
Prepared by author. 
 
      About 55.3% male and 46.6% young people 
(aged 15–24) have comprehensive knowledge of HIV 
in 2008–2012. Prevention among young people (aged 
15–24) who use condom with multiple partners is 
67.3% male and 37.1% female in 2008–2012 [51]. 
 
6.1 HIV Testing Facilities in Kenya 
      
      HIV testing facilities are increasing 
grammatically in Kenya. In 2000, there were just 3 
voluntary counseling and testing (VCT) sites in 
Kenya but in 2010 the sites become more than 4000. 
In 2008, about 860,000 people were being tested 
annually for HIV and in 2013; this had increased to 
6.4 million. From 2009 to 2013, the percentage of 
pregnant women tested for HIV increased from 68% 
to 92% [52]. VCT facilities are less among men than 
women in Kenya. In 2012, about 35.8% of men had a 
HIV test compared with 47.3% of women [31]. 
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       HIV testing rates among pregnant women have 
increased substantially. From 2009 to 2013, the 
percentage of pregnant women tested for HIV 
increased from 68% to 92% [52]. 
 
6.2 Antiretroviral Therapy (ART) in 
Kenya 
 
      In 2003, only 6,000 people living with HIV were 
given ART, but in 2013 this had increased to 
656,000. In 2006 President of Kenya announced that 
ART would be provided for free in public hospitals 
and health centers. In 2009 the number of people 
receiving ART had significantly increased to 336,980 
[52]. 
 
6.3 Effect of Economy for HIV Infection   
  
     Orphaned children are disadvantaged in schooling 
compared with children of non-HIV-infected parents. 
Fostered children also tend to be more 
undernourished than children of non-HIV-infected 
parents. Children of HIV infected parents are more 
likely to be underweight and wasted, less likely to be 
attending school, and less likely to receive medical 
advice and treatment when suffering from acute 
respiratory infections or diarrhea than children of 
non-HIV-infected parents [25]. 
     AIDS also has an impact on labor productivity. 
Under the relatively controlled conditions of a 
Kericho tea estate, AIDS sufferers show significant 
declines in the production [10]. 
     HIV infected persons compel to sell their 
household belongings for buying food and treatment. 
Sometimes HIV infected parents withdraw their 
children from school to provide care and engage 
them in child labor to maintain household 
expenditures. Sometimes women and children 
become the victims of sexual exploitation. As they 
have no other means except multiple sexual 
partnerships for supporting their families, which 
speeded HIV among the non-infected persons. When 
a woman’s husband died the widow lose all of her 
property, and her sons possess all the properties. 
Those subject to physical or sexual violence are 
unable to escape abusive partnerships, because 
divorce would mean their losing all rights to property 
[23]. 
 
6.4 HIV and TB Co-infection in Kenya 
       Kenya is considered to have one of the highest 
co-infection prevalence rates of HIV and TB in the 
world. About 60% of people with TB are co-infected 
with HIV and the mortality rate attributed to TB in 
this group being above 130 per 100, 000. Kenya has a 
target of reducing 50% TB deaths in HIV infected by 
2015. The percentage of estimated HIV-positive 
incident TB cases that received treatment for both TB 
and HIV increased from 56.4% in 2011 to 82.8% [37, 
40]. 
 
7. Infant and Child Health Care in 
Kenya 
 
      Each year more than 10.8 million children under-
5 die in the world mainly from preventable diseases 
that could be treated effectively. 42 countries account 
for 90% of child deaths while 6 countries account for 
50% of the deaths [4]. The lives of an estimated 6 
million children could be saved each year if 
antibiotics for pneumonia and oral rehydration 
therapy for diarrhea were universally available [14]. 
Only in 2012 more than 100,000 children died before 
their fifth birthday, largely due to preventable causes.  
About 13,000 new HIV infections occurred among 
children and 62% of children living with HIV did not 
access life-saving antiretroviral drugs [53]. 
      Kenya Demographic and Health Survey (KDHS) 
in 2003 expressed that 1 in every 9 children born dies 
before age five, mainly of acute respiratory infection, 
diarrhoea, measles, malaria, and malnutrition [58]. 
The Government of Kenyan (GoK) is also committed 
to the achievement of Millennium Development Goal 
number 4: reducing the infant and under-5 mortality 
rates to 21 and 32 per 1,000 childbirths respectively 
by the year 2015 [16]. 
      The mortality rate of children under-5 has been 
reduced by 36% between the 2003 and 2008–09 in 
Kenya from 115 to 74 deaths per 1,000 live births 
and the infant mortality rate has been reduced with 
32% from 77 deaths per 1,000 in 2003 to 52 deaths 
per 1,000 in the 2008–09 [15].  
 
8. Financing in Health Sector 
 
     According to the 2001–2002 National Health 
Accounts (NHA), Kenya spends 5.1% of its GDP on 
health. The health budget has grown significantly 
from Ksh15.2 billion in Fiscal 2001–02 to Ksh34.4 
billion in Fiscal year 2008–09. There are three major 
sources of financing for health services in Kenya: the 
government (central and local) contributes 30%, with 
households paying 51% out of pocket and donors 
(international and domestic) 16%; the legal National 
Hospital Insurance Fund (NHIF) and other private 
insurers and sources contribute the rest [42]. 
     Donor funding for the health sector as a share of 
the total budget has increased from 8% in Fiscal 
1994–95 to 16% in Fiscal 2001–02.  Major donors 
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include Japan, the US, the UK, and the European 
Commission [38].  
     Most of the people in Kenya have a high 
knowledge about HIV/AIDS and are aware of the 
prevention of this disease (98% among women and 
99% among men) but this knowledge is lower among 
the people aged 15–19 years. Health care has also 
improved in Kenya. Total expenditure on healthcare 
increased from Ksh 17.6 billion ($219 million) in 
2005 to Ksh 22.3 billion ($277.5 million) in 2007, 
and between 2004 and 2008 the number of health 
institutions increased by 19.8%. In 2008, the 
Government began providing free antiretroviral drugs 
(ARVs) to HIV-positive people and medical care is 
now free for under-5 children [12]. 
     In 2012, use of improved drinking water sources 
in Kenya is 60.9% (82.7% in urban and 54% in rural 
areas), use of improved sanitation facilities is 29.4% 
(31.1% in urban and 28.8% in rural areas). 
Immunization coverage in 2012 is as follows: BCG 
84%, DPT1-89%, DPT3-83%, polio3- 82%, MCV 
93%, HepB3-83%, Hib3-83%, tetanus (newborns) 
73%. Other health activities in Kenya are; care 
seeking for suspected pneumonia 55.9%, antibiotic 
treatment for suspected pneumonia 49.6%, diarrhoea 
treatment with oral rehydration saline (ORS) 38.8%, 
anti-malarial treatment among feverish children 
32.2%, malaria treatment of the children sleeping 
under Insecticide Treated Nets (ITNs) 46.7%, malaria 
treatment of the households with at least one ITN 
55.7% [51]. 
      The national TB program of Kenya requires an 
annual budget of about $62 million. The Government 
only allocates about $6 million. In 2010, the program 
received about $21.5 million of which only $7.4 
million [48].  
 
9. Health Management System 
 
       Management of healthcare at the district level is 
headed by a District Medical Officer of Health 
(DMOH) appointed by the Ministry of Health. The 
DMOH is supported by a District Health 
Management Board (DHMB) comprising officials 
appointed by the MoH and from local areas, and a 
professional unit, the District Health Management 
Team (DHMT). The DHMT prepares technical 
advisories and the District Health Plan in consultation 
with local health actors and the DHMB [33]. 
 
9.1 Opportunities of Kenya 
 
      Progressive rights-based constitution and clearly 
expressed Government strategies are as follows [49]: 
• Strong health partnerships which provide 
additional resources for addressing health 
challenges. 
• Robust private sector, economy and civil 
society strengthen service delivery capacity. 
• Regional and sub-regional integration 
provides opportunities for harmonization of 
cross-borders. 
 
9.1.1. Challenges of Kenya 
 
       High burden of communicable diseases and a 
growing burden of non-communicable diseases are as 
follows [49]: 
• Weak health systems characterized by 
inadequate health infrastructure, human 
resources and other health care inputs 
exacerbating distribution inequalities and 
health services utilization. 
• Persistent challenges in procurement, 
financial and information management to 
support health services decentralization. 
• Lack of comprehensive approach to 
intervention in some key areas. 
 
9.1.2. Development in Health Sector in 
Kenya 
 
       Before white man came to Kenya the people 
used herbs, animal parts, divination and others for 
treatment of diseases. After coming of the Christian 
missionaries and the colonial settlers’ modern 
medicine was introduced and established mission 
hospitals and clinics in Kenya. After independence 
the medical sector has developed with modern 
technologies and medicines [34]. 
      There are indications of ongoing improvements in 
the health status for infants and under-5. According 
to latest Kenya Demographic Health Survey (KDHS) 
[15], infant and under-5 mortality improved from 77 
and 115 to 52 and 74 per 1,000 live births 
respectively. Maternal and neonatal mortality, on the 
other hand, had shown stagnation since 1993. As a 
result, the country is not on track to meet its health 
MDG targets (4, 5 and 6). Furthermore, there are 
wide disparities in health status across the country, 
closely linked to underlying socio-economic, gender 
and geographical disparities. The country’s burden of 
communicable diseases remains high. HIV/AIDS is 
responsible for up to 29.3% of all deaths, and 24.2% 
of all disability in the country. Other causes of death 
include conditions during and just after birth (9% of 
deaths), respiratory (chest) infections including 
tuberculosis (14.4% of deaths), diarrhoeal diseases 
(6% of deaths), malaria (5.8% of deaths), stroke 
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(3.3% of deaths), heart attacks (2.8% of deaths), road 
traffic accidents (1.9% of deaths), and violence (1.6% 
of deaths). 
       Many interventions have been introduced, 
particularly since 2004, to address the high burden 
due to communicable diseases. As a result, 
investments in HIV, malaria, tuberculosis control, 
maternal and child health have been made. 
Additionally, investments in risk factors to health 
such as tobacco and alcohol use are being prioritized. 
These investments are complemented by investments 
in other health related sectors, such as in nutrition, 
access to safe water, education, roads, and others, to 
contribute to the overall improvement in health seen 
[15].  
      Kenya has recently experienced outbreaks of 
new/reemerging conditions such as polio and viral 
haemorrhagic fevers (e.g., dengue). Neglected 
tropical diseases such as lymphatic filariasis also 
remain a burden. Investments made since 2004 are 
now paying dividend [43]. 
     Malaria incidence and prevalence has significantly 
declined, as confirmed through 2010 community 
survey results, which showed a reduction of malaria 
parasitemia in the lake endemic areas among children 
under-5 by over 80% to 27% between 2002 and 2010 
as a result in part of increased ITN coverage. 
Following the 2011 campaign over 65% of the 
households in both endemic and epidemic malaria 
achieved universal coverage, i.e., at least one net for 
every two people in a household [44].  
      HIV prevalence declined from its peak of above 
10% in early 2003 to 6.3% in 2008 with a ratio of 2:1 
for women to men. Furthermore, nearly 78% of those 
in need of ART are now accessing it [62].  
     Estimated TB incidence has also come down from 
the peak of 450 cases per 100,000 populations in 
2005 to 200 in 2010. TB prevalence remains high at 
319 per 100,000, but the country has managed to 
maintain its achievement of 70% case detection rate 
and 85% treatment success rate since 2006 [66].  
     Non-communicable disease burden is on the rise; 
diabetes prevalence is estimated at 3.3%, and 13% of 
school-age children aged 13–15 years are active 
cigarette smokers. The country has ratified the 
Framework Convention on Tobacco Control (FCTC) 
and is party to International Health Regulation (IHR) 
2005. Sanitation-related illnesses like cholera remain 
a challenge in selected areas where adequate 
sanitation coverage remains low [43].  
 
10. Recommendations 
 
     To develop the health sector of Kenya adequate 
number of high skilled and experienced employees 
must be employed continuously, discourage 
ineffective recruitment, encourage monitoring of 
doctors and nurses, and ensure that performance and 
practice standards are met to enhance service quality 
provision. Medication services, patient satisfaction, 
good relationship between medical providers and 
patients have to give priority to improve the quality 
of hospital. Modern health services are needed with 
very low costs or free of cost to make the healthy 
nation in Kenya. Government of Kenya must increase 
budget in the health sector and provide sufficient free 
medical services to the poor. Various national and 
international NGOs and social conscious 
organizations must contribute to make the health 
sector in a standard form. 
 
11. Concluding Remarks 
 
        In this study we have discussed the health 
situation of Kenya. It is a developing country in the 
SSA. Childhood vaccination has to be increased in 
the country to reduce child morbidity and mortality 
rates. Infant and child mortality rate must be reduced 
to make a healthy nation in future. Every year a large 
number of Kenyans die due to curable and 
preventable diseases.  Government must try to reduce 
poverty from the country. So the people can spend 
sufficient amount of money to take the proper 
treatment and can take balance diet to prevent 
diseases. In the study we have observed that health 
care facilities in Kenya are not sufficient in the health 
sector. Social consciousness must be increased to 
prevent TB, malaria, HIV and some other infectious 
diseases. We hope the article is relevant topics from 
the public health aspects of the common people. 
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